Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Retained Earnings (2016 - 2026)

Heron Therapeutics filings provide 16 years of Retained Earnings readings, the most recent being -$6000.0 for Q1 2026.

  • On a quarterly basis, Retained Earnings rose 100.0% to -$6000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$6000.0, a 100.0% increase, with the full-year FY2025 number at $4000.0, down 69.23% from a year prior.
  • Retained Earnings hit -$6000.0 in Q1 2026 for Heron Therapeutics, down from $4000.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $40000.0 in Q3 2024 to a low of -$1.9 billion in Q3 2025.
  • Median Retained Earnings over the past 5 years was -$1.7 billion (2022), compared with a mean of -$978.3 million.
  • Biggest five-year swings in Retained Earnings: skyrocketed 100.0% in 2024 and later tumbled 31949216.67% in 2025.
  • Heron Therapeutics' Retained Earnings stood at -$19000.0 in 2022, then tumbled by 10031552.63% to -$1.9 billion in 2023, then skyrocketed by 100.0% to $13000.0 in 2024, then crashed by 69.23% to $4000.0 in 2025, then tumbled by 250.0% to -$6000.0 in 2026.
  • The last three reported values for Retained Earnings were -$6000.0 (Q1 2026), $4000.0 (Q4 2025), and -$1.9 billion (Q3 2025) per Business Quant data.